Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Cancer

Explore clinical trials studying Biliary Tract Cancer. Study availability and eligibility vary by location and protocol.

168 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Cancer trial results

Active, not recruiting

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

NCT05506943

Conditions
Adenocarcinoma, Ampullary Cancer, Biliary Tract Cancer, +13 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Medicine Cancer Center Palo Alto, California, United States
View all 34 locations
View Trial Details
Active, not recruiting

A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer

NCT03440450

Conditions
Advanced Solid Tumors, Biliary Tract Cancer, Biliary Tract Diseases, +5 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Hoag Memorial Hospital Comprehensive Cancer Center Newport Beach, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
View Trial Details
Active, not recruiting

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

NCT05775159

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Kansas City, Kansas, United States
View all 46 locations
View Trial Details
Active, not recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

NCT07021066

Conditions
Adenocarcinoma Of Esophagus, Advanced Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer, +9 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of Colorado Health Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View Trial Details
Active, not recruiting

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

NCT02711553

Conditions
Advanced Cancer, Biliary Tract Cancer, Biliary Tract Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
View all 82 locations
View Trial Details
Active, not recruiting

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

NCT06109779

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
View all 177 locations
View Trial Details
Active, not recruiting

SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer

NCT06465563

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University) Nanjing, Jiangsu, China
  • The First Affiliated Hospital，Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details

Related conditions